WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015034169) PHARMACEUTICAL COMPOSITION CONTAINING 3-(6-(4-(TRIFLUOROMETHOXY)PHENYLAMINO)PYRIMIDIN-4-YL)BENZAMIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/034169    International Application No.:    PCT/KR2014/005802
Publication Date: 12.03.2015 International Filing Date: 30.06.2014
IPC:
A61K 31/505 (2006.01), A61K 31/426 (2006.01), A61P 3/10 (2006.01)
Applicants: KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL [KR/KR]; 130, Dongdeok-ro Jung-gu Daegu 700-721 (KR).
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY [KR/KR]; 5, Hwarang-ro 14-gil Seongbuk-gu Seoul 136-130 (KR)
Inventors: LEE, In-Kyu; (KR).
KARUNAKARAN, Udayakumar; (KR).
KIM, Myoung Ok; (KR).
JEONG, Ji-Yun; (KR).
OH, Chang Joo; (KR).
JUN, Do Youn; (KR).
SIM, Tae Bo; (KR).
YOON, Ji Hye; (KR)
Agent: SHU, Jang-Chan; CHOI, KIM & PARTNERS, 4F., Yuhwa bldg., 23, Gomurae-ro 10-gil Secho-gu Seoul 137-802 (KR)
Priority Data:
10-2013-0107934 09.09.2013 KR
Title (EN) PHARMACEUTICAL COMPOSITION CONTAINING 3-(6-(4-(TRIFLUOROMETHOXY)PHENYLAMINO)PYRIMIDIN-4-YL)BENZAMIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING DIABETES
(FR) COMPOSITION PHARMACEUTIQUE CONTENANT DU 3-(6-(4-(TRIFLUOROMÉTHOXY)PHÉNYLAMINO)PYRIMIDINE-4-YL)BENZAMIDE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CE DERNIER COMME PRINCIPE ACTIF POUR PRÉVENIR OU TRAITER UN DIABÈTE
(KO) 3-(6-(4-(트리플루오로메톡시)페닐아미노)피리미딘-4-일)벤자미드 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 당뇨병의 예방 또는 치료용 약학적 조성물
Abstract: front page image
(EN)The present invention relates to a pharmaceutical composition and functional health food containing 3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide or a pharmaceutically acceptable salt thereof as an active ingredient for preventing or treating diabetes. The 3-(6-(4-(trifluoromethoxy)phenylamino)pyrimidin-4-yl)benzamide or the pharmaceutically acceptable salt thereof according to the present invention can be effectively used to treat diabetes including type 1 diabetes and type 2 diabetes, and the compound can be used as a functional health food for preventing or ameliorating diabetes.
(FR)La présente invention concerne une composition pharmaceutique et un aliment fonctionnel contenant du 3-(6-(4-(trifluorométhoxy)phénylamino)pyrimidine-4-yl)benzamide ou un sel pharmaceutiquement acceptable de ce dernier comme principe actif pour prévenir ou traiter un diabète. Le 3-(6-(4-(trifluorométhoxy)phénylamino)pyrimidine-4-yl)benzamide ou le sel pharmaceutiquement acceptable de ce dernier selon la présente invention peut être utilisé efficacement pour traiter un diabète, y compris un diabète de type 1 et un diabète de type 2, et le composé peut être utilisé comme aliment fonctionnel pour prévenir ou améliorer un diabète.
(KO)본 발명은 3-(6-(4-(트리플루오로메톡시)페닐아미노)피리미딘-4-일)벤자미드 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 당뇨병(diabetes)의 예방 또는 치료용 약학적 조성물 및 건강기능식품에 관한 것이다. 본 발명에 따른 3-(6-(4-(트리플루오로메톡시)페닐아미노)피리미딘-4-일)벤자미드 또는 이의 약학적으로 허용 가능한 염은 제 1형 당뇨병 및 제 2형 당뇨병을 포함한 당뇨병의 치료에 효과적으로 사용될 수 있으며, 상기 화합물은 당뇨병의 예방 또는 개선용 건강기능식품의 용도로서도 사용될 수도 있다.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Korean (KO)
Filing Language: Korean (KO)